Peng-hui Luo

Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Survival Nomogram for Stage IV (M1a-c) Melanoma: A Population-Based Study Highlighting the Prognostic Correlates of Surgery in Pre-Immunotherapy and Early Immunotherapy Eras.

Survival Nomogram for Stage IV (M1a-c) Melanoma: A Population-Based Study Highlighting the Prognostic Correlates of Surgery in Pre-Immunotherapy and Early Immunotherapy Eras.

Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research

Published: July 14, 2026

Association of primary lesion surgery and surgical modality with overall survival in patients with stage IV cutaneous melanoma: a population-based study.

Association of primary lesion surgery and surgical modality with overall survival in patients with stage IV cutaneous melanoma: a population-based study.

Journal: Translational cancer research

Published: February 08, 2026

Letter to the editor: Variations in the atlantoaxial joint detected by computed tomography in control patients.

Letter to the editor: Variations in the atlantoaxial joint detected by computed tomography in control patients.

Journal: Radiography (London, England : 1995)

Published: October 16, 2025

The role of PD-L1 in patients with non-small cell lung cancer receiving neoadjuvant immune checkpoint inhibitor plus chemotherapy: a meta-analysis.

The role of PD-L1 in patients with non-small cell lung cancer receiving neoadjuvant immune checkpoint inhibitor plus chemotherapy: a meta-analysis.

Journal: Scientific reports

Published: July 06, 2024

Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab.

Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 07, 2024

Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trial.

Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trial.

Journal: Lancet (London, England)

Published: December 15, 2023

Tucatinib Plus Trastuzumab and Capecitabine for ERBB2 (HER2)-Positive Metastatic Breast Cancer With Brain Metastases.

Tucatinib Plus Trastuzumab and Capecitabine for ERBB2 (HER2)-Positive Metastatic Breast Cancer With Brain Metastases.

Journal: JAMA oncology

Published: May 25, 2023

Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma.

Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma.

Journal: The Lancet. Oncology

Published: April 06, 2023

Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis.

Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis.

Journal: Frontiers in immunology

Published: March 30, 2023

Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma.

Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 20, 2023

Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer.

Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 20, 2023

Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma.

Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma.

Journal: The Lancet. Oncology

Published: November 07, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026